retatrutide triple agonist obesity trial glp-1 gip glucagon phase 2 is gaining attention in metabolic retatrutide triple agonist phase 2

COMPREHENSIVE 6-IN-1 SUPPORT FOR MODERN WEIGHT MANAGEMENT*: Supports GLP-1 activity, blood glucose, appetite, metabolism, gut health, and immune function-all in one streamlined formula.* Designed for those pursuing weight loss, enhancing GLP-1 activity naturally, complementing GLP-1 medications, or seeking a non-drug alternative, with an easy-to-integrate daily capsule routine

doi: 10.1210/clinem/dgab722 58 ForzanoIVarzidehFAvvisatoRJankauskasSSMonePSantulliG

Retatrutide achieved 24.2% in 48 weeks

Who Should Not Use Mounjaro or Tirzepatide

Legitimate GLP-1 treatments like Mounjaro and Wegovy require a prescription because they're regulated medicines that need to be assessed by a healthcare professional

the Take-Away A new class of diabetes and weight-loss drugs is drawing attention from researchers, and the early data on opioid addiction may be the most compelling signal yet